A significantly lower percentage of CD19+ TLR9+ B cells (p <0.001) and CD8+ TLR9+ T cells (p = 0.016) was demonstrated in patients with newly diagnosed diabetes. This evidence concerns the gene CD19 and diabetes mellitus.